Q-VANT Biosciences enters Vaccine Research Master Agreement with Kansas State University Teams to study the impact of saponin-based adjuvants on animal vaccine efficacy
BOSTON, MA – April 12, 2022 – Q-VANT Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market...
Read more
Recent Comments